Microbot Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $105KTTM through 30 Jun 2026
Net Income -$16.3MTTM through 30 Jun 2026
Free Cash Flow -$17.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 1.9% |
| Operating Margin | -4,114.3% |
| Net Margin | -3,496.2% |
Returns
-21.8%ROE
-18.2%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio22.59x
Net Debt-$72.5Mnet cash position
Cash & Equivalents$3.2M
Quality Metrics
Altman Z-Score10.65
Piotroski F-Score0 / 9
FCF Margin-17,075.2%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2015: $116.9K
Diluted EPS-$0.25TTMFY2025: $-0.29
Dividend
No dividend
Capital Allocation
Capex Intensity274.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Robotic devices for endoluminal surgery | $105K | View detailsThe company expects to scale manufacturing and commercialization of the LIBERTY system following its limited market release and full market release. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.